US 8338102
Method of diagnosing poor survival prognosis colon cancer using miR-181b
granted A61PA61P1/04A61P35/00
Quick answer
US patent 8338102 (Method of diagnosing poor survival prognosis colon cancer using miR-181b) held by The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer
- Grant date
- Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/04, A61P35/00